TrialAlimentary pharmacology & therapeutics2016

Impact of patient characteristics on the clinical efficacy of mongersen (GED-0301), an oral Smad7 antisense oligonucleotide, in active Crohn's disease.

G Monteleone et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.